Journey Clinical

We are thrilled to announce that Journey Clinical now accepts Aetna insurance in New York and California! This milestone marks a major step forward in Journey Clinical’s mission to expand access to innovative, evidence-based mental health treatments to the millions of people in the U.S. living with depression and anxiety. In the coming months, we will be partnering with all major insurance providers in our active states to reach as many people as possible. With insurance coverage, Journey Clinical now offers a comprehensive behavioral health solution for licensed mental health professionals and eligible patients, including psychiatric medication management and Ketamine-Assisted Psychotherapy. Through the power of collaborative care and our innovative mental health treatments, we are transforming the fragmented healthcare system to accelerate the improvement of patient outcomes and provide the highest standard of care. At Journey Clinical, licensed therapists join our membership to gain access to a world-class psychiatry team, becoming our partners in delivering high quality collaborative care to our shared clients. Journey Clinical serves as therapists’ in-house doctor and private practice partner, providing unprecedented access to comprehensive training, education, resources and the largest community therapists in the U.S. Journey Clinical’s patients gain access to innovative treatments like Ketamine-Assisted psychotherapy, insurance-covered psychiatric services, and a world class collaborative care team to holistically support their treatment journey. You can learn more about insurance coverage at Journey Clinical and how to get started at https://lnkd.in/eNHR4VtA

Listen to the newest episode of The New Health Club Show featuring Journey Clinical Co-founder and CEO Jonathan Sabbagh: https://lnkd.in/eqT8tztX In this episode, Jonathan narrates his personal psychedelic therapy experience and its role in shaping Journey Clinical’s mission and business framework.

We're hitting the road to connect with our California community! 🌞🌴 We will be hosting special panels featuring our medical leadership and member psychotherapists and celebrating the Ketamine-Assisted Psychotherapy (KAP) movement with our members and local psychotherapists. This is a wonderful opportunity to connect with like-minded professionals, share experiences, and expand your network in a lively and welcoming environment! July 21 - Los Angeles - RSVP: https://bit.ly/4d5grUN July 23 - San Diego - RSVP: https://bit.ly/3xLACrW July 24 - SF Bay Area - RSVP: https://bit.ly/3S6366k July 25 - Santa Cruz - RSVP: https://bit.ly/3S2Qvkj We hope to see you there! Featuring our incredible panelists: Katrina Olive, Brian Shiers, MA CMF LMFT, Denise Williams, L.J. Lumpkin III, Breanne Ferrara, LCSW, Chandra Khalifian, Brooke Kettering, MA, LMFT, Kwasi Adusei, Jodie NewDelman, Psy.D., & Gwen Pelfini, LMHC, LPCC, NCC, PATP

Journey Clinical was featured in Forbes for our research collaboration with Compass Pathways to inform how COMP360 psilocybin treatment may be delivered to patients with treatment-resistant depression across the US, if approved. “With a network of more than 2,000 therapists and a comprehensive training and education program, Journey Clinical has the infrastructure to support broad access to innovative psychedelic treatments for mental health conditions.” Pioneering mental health treatments, like investigational COMP360 psilocybin therapy, are showing promise in providing relief to those suffering from treatment-resistant depression (TRD). In the article, Steve Levine, MD, SVP of Patient Access and Medical Affairs at Compass Pathways, highlighted Journey Clinical’s research collaboration aimed at developing a scalable delivery and training model for COMP360 psilocybin treatment. Our partnership with Compass Pathways is a testament to Journey Clinical’s mission to transform the mental health landscape by empowering licensed psychotherapists to deliver evidence-based Psychedelic-Assisted Psychotherapy safely and effectively. Learn more about this research collaboration: https://lnkd.in/gP3u5WvV

Excited by this! Journey Clinical The New Health Club

Collaborative care is at the heart of Journey Clinical. Journey Clinical Lead Clinician, Brigitte Gordon, DNP, PMHNP-BC, spoke about our patient-centered collaborative care model at last month’s Fluence X Journey Clinical community event. Within our model, Journey Clinical’s highly trained, in-house medical team partners with licensed psychotherapists in our network to deliver the highest quality of care to our shared patients. During the event, Brigitte spoke about the sensitivity and care that goes into all medical responsibilities of Ketamine-Assisted Psychotherapy to ensure that each patient receives a tailored experience. If you’re a licensed mental health professional looking to begin your own Ketamine-Assisted Psychotherapy (KAP) practice with Journey Clinical, or a potential patient interested in learning more about KAP treatment, visit: https://lnkd.in/egp42SXM

“These attributes potentially improve the scalability of ketamine use in the community, due to reduced need for in-clinic monitoring, and would also reduce costs associated with clinic visits.” Writer Anuradha Varanasi recently reported on the findings of a clinical trial testing ketamine tablets as a treatment for treatment-resistant depression. Varanasi notes: “The team observed that while 71% of the patients in the placebo group experienced a relapse of a depressive episode, in the group of patients who took 180 mg of ketamine tablets as prescribed, only 43% of patients reported a relapse.” To learn more about whether Ketamine-Assisted Psychotherapy (KAP) treatment would be a good fit for you, please visit: https://bit.ly/3Laycpw

According to the APA, 45% of adults ages 35 to 44 reported living with mental illness in 2023 – skyrocketing from 31% in 2019. At Journey Clinical, we believe Ketamine-Assisted Psychotherapy can be a powerful tool to help patients create lasting change, break free from old thought patterns, and embrace new perspectives. Psychotherapy with a trusted clinician is a key component of the treatment process. If you’re a licensed mental health professional looking to begin your own Ketamine-Assisted Psychotherapy (KAP) practice with Journey Clinical, or a prospective patient interested in learning more about KAP treatment, visit: https://lnkd.in/egp42SXM

This is incredible - Watch one of our members, Chrissy Powers, LMFT, experience KAP for the first time before becoming a Journey Clinical KAP Provider. Thank you, Chrissy, for sharing your experience and for being a wonderful member of our community: “THERAPY VLOG: My First Ketamine Assisted Therapy experience back in 2022. I thought I was doing this all in the name if research, but I ended up healing parts of my inner child and now 2 years later I'm a certified KAP therapist. Click the link in my bio to join my Substack where I'll be sharing the full video and more details in KAP. #KetamineTherapy #therapywithchrissy #MentalHealth #HealingJourney #journeyclinical @journeyclinical” (via @chrissyjpowers on IG) If you’re a licensed mental health professional looking to begin your own KAP practice with Journey Clinical, or a potential patient interested in learning more about KAP treatment, visit https://lnkd.in/egp42SXM

Thank you, Yamil S. for spreading the word! NYC Ketamine-Assisted Psychotherapists (and those interested in learning more about psychedelic therapy) - join us and Juanita Viera, LCAT tonight for an evening of discovery and connection, featuring a sound bath and art-making experience. We hope to see you there! RSVP here: https://lnkd.in/ewnSuFrw